QuantHealth Gathers Pharma and Tech Leaders to Scale AI in Clinical Trials
Event summary
- QuantHealth's AI in Clinical Development Summit will convene on May 27, 2026, in New York City.
- The event features C-suite leaders from AstraZeneca, Bristol Myers Squibb, Sanofi, and Roche.
- QuantHealth partners Accenture, AWS, Databricks, and ZS will also participate.
- Summit focuses on scaling AI adoption in clinical trials with measurable outcomes.
The big picture
QuantHealth is positioning itself as the bridge between AI innovation and practical implementation in clinical trials. With 12 of the top 20 pharma companies as partners, this summit represents a critical juncture where proof-of-concept transitions to enterprise-wide adoption. The event underscores the industry's shift from theoretical AI potential to tangible outcomes that accelerate drug development timelines.
What we're watching
- AI Scalability
- How QuantHealth will demonstrate measurable impact from AI implementations across large pharma organizations.
- Regulatory Confidence
- Whether the summit can bridge gaps between regulatory uncertainty and commercialization readiness for AI-driven trials.
- Competitive Differentiation
- The pace at which QuantHealth's real-world data sets will drive sustained competitive advantage in clinical development.
Related topics